Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
CA 2316767 A1 · Owner: Ricketts, Anthony Paul · Inventors: Cole, Bridget Mccarthy; Ricketts, Anthony Paul; Hay, Bruce Allan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds according to the formula:, and pharmaceutically acceptable salts solvates or hydrates thereof; wherein group, Ar is optionally substituted (C6-C10)aryl or (C1-C9)heteroaryl; X is a direct link, -CH2 -, -SO2 -, -CO-, -CHR1- where R1 is(C1-C6) alkyl or -CR1'R" - where both R1' and R" are independently, (C1-C6)alkyl; Y is N or CH; and Z and W are as herein defined and , pharmaceutical, compositions thereof and methods useful to facilitate secretion of growth hormone(GH) in, mammals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 29, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 29, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.